Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Natália Mesquita Brito
Observed name:
Natália Brito
Institution:
Libbs (Brazil)
Observed institution:
Libbs (Brazil)
ORCID:
0000-0003-4301-5942
Observed ORCID:
0000-0003-4301-5942
OpenAlex ID:
A5022938970
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population
2024
·
Debora Gagliato
, Tomás Reinert
, et al.
·
Oncology and Therapy
·
6
A prospective real-world study to assess the effectiveness and safety of trastuzumab biosimilar in the adjuvant treatment of HER2-positive breast cancer: Preliminary safety results.
2023
·
Ana Carolina Ferreira Cardoso
, Debora De Melo Gagliato
, et al.
·
Journal of Clinical Oncology
·
1
A prospective real-world study to assess the effectiveness and safety of trastuzumab biosimilar in the adjuvant treatment of HER2-positive breast cancer: Preliminary safety results.
2022
·
Ana Carolina Ferreira Cardoso
, Debora De Melo Gagliato
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
3
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type
